Skip to main content
Psychedelic State(s) of America
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Vicentellp

Published November 5, 2026 · Updated November 6, 2026

Sean Clancy Attends 2026 Hopkins-Oxford Psychedelic Ethics (HOPE) Meeting in Washington, D.C.

Read the full story at Vicentellp

On September 24–25, 2026, Vicente counsel Sean Clancy attended the fourth meeting of the Hopkins-Oxford Psychedelic Ethics (HOPE) working group at.

Post on X

Share this story

Share on XShare on LinkedInShare on FacebookShare on WhatsAppShare on Signal

Surfaced by 3 Google Alerts

  • Psychedelics
  • MDMA
  • Psychedelic press release